Dr. Cody Vanlandingham, M.D.
What this data tells you about Dr. Vanlandingham
Dr. Cody Vanlandingham is a family medicine in Tallahassee, FL, with 17 years in practice. Based on federal Medicare data, Dr. Vanlandingham performed 3,467 Medicare services across 2,496 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vanlandingham received a total of $4,387 from 31 pharmaceutical and/or device companies across 262 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vanlandingham is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 717 | $85 | $172 |
| Office visit, established patient (20-29 min) | 493 | $60 | $119 |
| Advance care planning consultation, first 30 min | 234 | $81 | $137 |
| Annual alcohol misuse screening, 5 to 15 minutes | 226 | $18 | $30 |
| Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | 224 | $26 | $42 |
| Annual wellness visit, follow-up | 203 | $127 | $182 |
| Annual depression screening | 203 | $18 | $30 |
| Drug injection, under skin or into muscle | 124 | $10 | $41 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 123 | $22 | $35 |
| Flu vaccine administration | 120 | $30 | $34 |
| Dexamethasone injection (steroid) | 113 | $0 | $10 |
| Ceftriaxone antibiotic injection | 100 | $0 | $40 |
| Detection test by immunoassay with direct visual observation for influenza virus | 93 | $16 | $54 |
| Face-to-face behavioral counseling for obesity, 15 minutes | 60 | $26 | $42 |
| Urinalysis, manual | 59 | $3 | $12 |
| Pneumonia vaccine administration | 58 | $30 | $34 |
| Electrocardiogram (EKG), 12-lead | 52 | $10 | $80 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 50 | $1 | $20 |
| Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | 47 | $34 | $100 |
| Pneumococcal vaccine, 23-valent | 35 | $131 | $135 |
| Transitional care management services for problem of at least moderate complexity | 32 | $146 | $292 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 29 | $163 | $276 |
| Pneumococcal vaccine, 13-valent | 24 | $251 | $256 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 22 | $15 | $54 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 15 | $38 | $114 |
| Transitional care management services for problem of high complexity | 11 | $216 | $412 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Vanlandingham is a clinical cardiology specialist, with above-average Medicare volume (top 9% in FL), and high industry engagement (low-engagement, top 12%), with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Vanlandingham experienced with office visit, established patient (30-39 min)?
Does Dr. Vanlandingham receive payments from pharmaceutical companies?
How do Dr. Vanlandingham's costs compare to other family medicines in Tallahassee?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology